Clinical Trials Arena on MSN18h
OSE announces overall survival success in Phase II PDAC vaccine trialThe Phase II trial examined the therapeutic cancer vaccine Tedopi in combination with chemotherapy drug combination FOLFIRI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback